Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Coagulation factor XIII B/F13B Antibody (9G131) is a Rabbit antibody targeting Coagulation factor XIII B/F13B. Anti-Coagulation factor XIII B/F13B Antibody (9G131) can be used in ELISA,ELISA(Cap).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 20 μL | $92 | 7-10 days | 7-10 days | |
| 100 μL | $270 | 7-10 days | 7-10 days |
| Description | Anti-Coagulation factor XIII B/F13B Antibody (9G131) is a Rabbit antibody targeting Coagulation factor XIII B/F13B. Anti-Coagulation factor XIII B/F13B Antibody (9G131) can be used in ELISA,ELISA(Cap). |
| Synonyms | FXIIIB, coagulation factor XIII, B polypeptide, Coagulation factor XIII, Coagulation factor 13 |
| Ig Type | Rabbit IgG |
| Clone | 9G131 |
| Reactivity | Human |
| Specificity | Human Factor XIII |
| Application | |
| Recommended Dose | ELISA: 1:5000-1:10000; ELISA(Cap): 1:250-1:2000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human Coagulation Factor XIII B chain / F13B (rh Coagulation Factor XIII B chain / F13B; TMPY-02185; P05160; Met1-Thr661). |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | Coagulation factor XIII B chain, also known as Fibrin-stabilizing factor B subunit, Protein-glutamine gamma-glutamyltransferase B chain, Transglutaminase B chain and F13B, is a secreted protein which contains 1 Sushi ( CCP / SCR ) domains. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is composed of just 2 A subunits, which are identical to those of plasma origin. The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin. Factor XIII acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. Defects in F13B are the cause of factor XIII subunit B deficiency ( FA13BD ) which is an autosomal recessive disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human Coagulation Factor XIII B chain / F13B Protein (TMPY-02185) |
| Antigen Species | Human |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.